2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$1.88-$0.01 (-0.79%)
Price as of Jun 03, 2026 6:33 PM EDT- $968.3MMarket Cap
- 199.05%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$1.88-$0.01 (-0.79%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.89 | ||
Change | -$0.18 (-8.70%) | ||
Open | $2.09 | ||
High | $2.09 | ||
Low | $1.88 | ||
Previous Close | $2.07 | ||
Volume | 3,157,449 | ||
30-Day Average Volume | 3,213,701 | ||
1-Week Change | -8.25% | ||
1-Month Change | 15.95% | ||
1-Year Change | 199.05% | ||
3-Year Change | -31.15% | ||
5-Year Change | -58.82% | ||
Fundamentals | |||
Shares Outstanding | 444.2M | ||
Total Assets | $268.8M | ||
Market Cap | $968.3M | ||
Enterprise Value | $979.9M | ||
Period: QTR TTM FY | |||
Revenue | $21.1M | ||
Net Income | -$1.0M | ||
Free Cash Flow | -$14.7M | ||
EBIT | -$1.0M | ||
EBITDA | -$933,000.00 | ||
Net Working Capital | $176.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -1,050 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 5 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue